Search results
Showing 721 to 735 of 1094 results for infections
NICE has developed a medtech innovation briefing (MIB) on WoundExpress to manage lower leg wounds .
encephalopathy there is a clearly defined precipitating factor (for example, infections, gastrointestinal bleeding or overuse of...
Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease.
Infracoccygeal sacropexy using mesh to repair uterine prolapse (HTG443)
Evidence-based recommendations on infracoccygeal sacropexy using mesh to repair uterine prolapse in women. This involves attaching mesh from the buttocks to the top of the vagina to hold the uterus in place.
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions (MIB295)
NICE has developed a medtech innovation briefing (MIB) on ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions .
This guideline covers the diagnosis and management of tension-type headache, migraine (including migraine with aura and menstrual-related migraine), cluster headache and medication overuse headache in young people (aged 12 years and older) and adults. It aims to improve the recognition and management of headaches, with more targeted treatment to improve the quality of life for people with headaches, and to reduce unnecessary investigations.
monitor and evaluate the rates (and recurrent rates) of foot ulceration, infection and gangrene resulting from diabetes, rates and...
The proposed study would monitor and evaluate the rates of foot ulcer or infection resulting from diabetes, rates and extent of...
Summary of the evidence on rifaximin for treating pouchitis to inform local NHS planning and decision-making
Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (NG245)
This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks. It does not cover managing severe asthma or acute asthma attacks.
Ustekinumab for treating moderate to severe plaque psoriasis (TA180)
Evidence-based recommendations on ustekinumab (Stelara) for treating psoriasis in adults.
Sofosbuvir–velpatasvir for treating chronic hepatitis C (TA430)
Evidence-based recommendations on sofosbuvir–velpatasvir (Epclusa) for treating chronic hepatitis C in adults.
Maribavir for cytomegalovirus infection after haematopoietic stem cell transplant [ID5075]
Discontinued Reference number: GID-TA10958
Bezlotoxumab for preventing recurrent Clostridium difficile infection (terminated appraisal) (TA601)
This guidance has been updated and replaced by NICE guideline NG199.
Dapagliflozin in triple therapy for treating type 2 diabetes (TA418)
Evidence-based recommendations on dapagliflozin (Forxiga) given with 2 other drugs for treating type 2 diabetes in adults.